In Defense of Secondary Pharmaceutical Patents in Drug Discovery and Development-Reference-Cited by-同舟云学术

In Defense of Secondary Pharmaceutical Patents in Drug Discovery and Development

Published:2020-02-13 Issue:2 Volume:11 Page:91-98
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Agranat Israel¹^ORCID,Marom Hili¹^ORCID

Affiliation:

1. Organic Chemistry, Institute of Chemistry, The Hebrew University of Jerusalem, Philadelphia Bldg. #212, Edmond J. Safra Campus, Jerusalem 9190401, Israel

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.9b00497

Reference17 articles.

1. Correa, C. M. Guidelines for Pharmaceutical Patent Examination: Examining Pharmaceutical Patents from a Public Health Perspective; United Nations Development Programme: New York, 2015; pp 1–44.

2. In Defense of Secondary Pharmaceutical Patents: A Response to the UN's Guidelines for Pharmaceutical Patent Examination

3. Ellery, T.; Hansen, N. Pharmaceutical lifecycle management: making the most of each and every brand; Wiley: Hoboken, NJ, 2012; pp 161, 344–351.

4. The strategy of enantiomer patents of drugs

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aromaticity – a theoretical notion;Structural Chemistry;2024-04-23

2. Neuroenhancement Patentability and the Boundaries Conundrum in Psychiatric DisordersComparative Regulatory Inquiries from China and the West;EUR J COMP LAW GOV;2024

3. Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2;Journal of Pharmaceutical and Biomedical Analysis;2024-01

4. Proprietary strategies in precision medicine;Comprehensive Precision Medicine;2024

5. Widened Scope of Drug Repurposing/Chiral Switches, Elements of Secondary Pharmaceuticals: The Quinine/Quinidine Case;Future Drug Discovery;2023-11